Difference between revisions of "Association of the British Pharmaceutical Industry Scotland"

From Powerbase
Jump to: navigation, search
(References)
 
(14 intermediate revisions by one other user not shown)
Line 5: Line 5:
 
ABPI commissioned a pharmaco-economic research from [[NERA Economic Consulting]] on two particular disease areas in Scotland—coronary heart disease and diabetes showing that the level of expenditure on cholesterol lowering medicines—statins is still profitable for NHS in overall terms. <ref>[http://www.scottish.parliament.uk/business/committees/health/or-06/he06-1602.htm Scottish Parliament Health Committee Official Report 20 June 2006]</ref>
 
ABPI commissioned a pharmaco-economic research from [[NERA Economic Consulting]] on two particular disease areas in Scotland—coronary heart disease and diabetes showing that the level of expenditure on cholesterol lowering medicines—statins is still profitable for NHS in overall terms. <ref>[http://www.scottish.parliament.uk/business/committees/health/or-06/he06-1602.htm Scottish Parliament Health Committee Official Report 20 June 2006]</ref>
  
 +
In 2002 nurses became authorised to write out prescriptions and since then they have been bombarded with approaches from pharmaceutical companies. This new link between nurses and representatives of pharmaceutical companies is receiving much attention after the doctors/pharma link:
 +
 +
"prescribing decisions may be affected by a 'free lunch culture' which sees doctors whisked off to conferences and briefing seminars that are often held in plush hotels or overseas."<ref>[http://www.redorbit.com/news/health/106892/prescription_pressures_from_drug_companies_not_what_the_nurses_ordered/ Prescription Pressures From Drug Companies Not What the Nurses Ordered] Red Orbit, 29 November 2004</ref>
 +
 +
In responce to accusations, the spokesman of ABPI Scotland claimed that the industry cannot influence the choices nurses make:
 +
'The patient is protected by a number of safeguards. First of all the industry is very regulated in what kind of hospitality can be offered...The values of gifts are limited to GBP 6 and hospitality may not be worth more than the medical professional could normally afford. The professions are also protected by their own rules and guidelines, which insist that they must always act only in the interests of the patient.'<ref>[http://www.redorbit.com/news/health/106892/prescription_pressures_from_drug_companies_not_what_the_nurses_ordered/ Prescription Pressures From Drug Companies Not What the Nurses Ordered] Red Orbit, 29 November 2004</ref>
 +
 +
 +
==Location==
 
Third Floor East, Crichton House, 4 [[Crichton’s Close]], Canongate, Edinburgh, EH8 8DT
 
Third Floor East, Crichton House, 4 [[Crichton’s Close]], Canongate, Edinburgh, EH8 8DT
 
Telephone: +44 (0) 870 890 4333
 
Telephone: +44 (0) 870 890 4333
Line 11: Line 20:
 
==People==
 
==People==
 
[[Jim Eadie]]
 
[[Jim Eadie]]
 +
 +
[[Dot Anderson]]
 +
 +
[[Kim Fellows]]
 +
 +
[[John Patterson]]
  
 
==Affiliations==
 
==Affiliations==
 +
[[Scottish Diabetes Industry Group]] was set up in 2002 under the auspices of the ABPI Scotland
  
 
The Royal College of Physicians
 
The Royal College of Physicians
 +
 +
[[National Institute of Clinical Excellence (NICE)]]
 +
 +
[[Health Technology Board for Scotland (HTBS)]]
 +
 +
[[NHS Quality Improvement Scotland]]
  
 
===References===
 
===References===
 
<references/>
 
<references/>
[[Category:Pharma Lobby Groups]]
+
[[Category:Pharma Lobby Groups]][[Category:Scottish Corporate Lobby Groups]]

Latest revision as of 00:00, 11 November 2008

The ABPI in Scotland is an arm of the Association of the British Pharmaceutical Industry. It works together with the Scottish Parliament, patients, healthcare professionals and managers of the NHS to 'ensure that the people of Scotland have access to the best quality healthcare, including modern medicines'.[1]

The ABPI represents 75 companies in the United Kingdom that research, manufacture and supply 80 per cent of the medicines that the national health service prescribes.

ABPI commissioned a pharmaco-economic research from NERA Economic Consulting on two particular disease areas in Scotland—coronary heart disease and diabetes showing that the level of expenditure on cholesterol lowering medicines—statins is still profitable for NHS in overall terms. [2]

In 2002 nurses became authorised to write out prescriptions and since then they have been bombarded with approaches from pharmaceutical companies. This new link between nurses and representatives of pharmaceutical companies is receiving much attention after the doctors/pharma link:

"prescribing decisions may be affected by a 'free lunch culture' which sees doctors whisked off to conferences and briefing seminars that are often held in plush hotels or overseas."[3]

In responce to accusations, the spokesman of ABPI Scotland claimed that the industry cannot influence the choices nurses make: 'The patient is protected by a number of safeguards. First of all the industry is very regulated in what kind of hospitality can be offered...The values of gifts are limited to GBP 6 and hospitality may not be worth more than the medical professional could normally afford. The professions are also protected by their own rules and guidelines, which insist that they must always act only in the interests of the patient.'[4]


Location

Third Floor East, Crichton House, 4 Crichton’s Close, Canongate, Edinburgh, EH8 8DT Telephone: +44 (0) 870 890 4333 Fax: +44 (0) 131 523 0491

People

Jim Eadie

Dot Anderson

Kim Fellows

John Patterson

Affiliations

Scottish Diabetes Industry Group was set up in 2002 under the auspices of the ABPI Scotland

The Royal College of Physicians

National Institute of Clinical Excellence (NICE)

Health Technology Board for Scotland (HTBS)

NHS Quality Improvement Scotland

References